drugset / Trial / NCT00365261

Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer

NCT00365261

Phase 4 Completed 45 enrolled University of California, San Diego
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the effectiveness of Lunesta on cancer patients who have received chemotherapy and who require patient controlled analgesia (PCA), specifically to assess whether Lunesta will: * improve sleep thereby decreasing need for opiates via PCA * improve sleep thereby decreasing pain by self report * improve sleep thereby decreasing fatigue by self report

Timeline

Start
2006-09
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eszopiclone Small molecule 2 mg
Comparator Eszopiclone Small molecule 3 mg